Acasă › Cancer pulmonar › Connecticut › New Haven
Studii clinice pentru Cancer pulmonar în New Haven, CT
22 studii pentru Cancer pulmonar caută participanți în și în jurul orașului New Haven (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · La 3 mi distanță
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · La 3 mi distanță
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- și încă 2
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
În curs de recrutareFaza 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- Smilow Cancer Hospital-Derby Care Center, Derby · La 8 mi distanță
- și încă 1
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 2
- Yale Cancer Center, New Haven
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
În curs de recrutareFaza 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- și încă 1
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
În curs de recrutareFaza 2
- Research Site, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
În curs de recrutareFaza 1
- Yale Cancer Center, New Haven
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
În curs de recrutareFaza 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
În curs de recrutareFaza 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
În curs de recrutareFaza 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
În curs de recrutareFaza 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · La 5 mi distanță
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- și încă 2
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
În curs de recrutareFaza 1
- Smilow Cancer Hospital (Yale University), New Haven
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- Smilow Cancer Hospital-Derby Care Center, Derby · La 8 mi distanță
- și încă 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- Smilow Cancer Hospital-Derby Care Center, Derby · La 8 mi distanță
- și încă 1
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
În curs de recrutareVoluntari sănătoși bineveniți
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
În curs de recrutareStudiu observațional
- Yale School of Medicine, New Haven
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Arlington, VA41 studii
- Washington, DC41 studii
- Chicago, IL41 studii
- Baltimore, MD40 studii
- Nashville, TN40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în New Haven
- Cancer pulmonar cu celule non-pătrate41 studii
- Cancer de sân38 studii
- Cancer (toate tipurile)33 studii
- Cancer metastatic23 studii
- Carcinom cu celule scuamoase de cap și gât22 studii
- Cancer ovarian21 studii
- Cancer colorectal20 studii
- Cancer de prostată20 studii
- Leucemie mieloasă acută17 studii
- Tulburare de utilizare a alcoolului (AUD)17 studii
- Supradozaj cu opioide17 studii
- Cancer pancreatic16 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.